CNS pipeline · person
Nick Kurahashi, MS
Executive Vice President, Global Pharmaceutical Strategy at Otsuka Pharmaceutical Development & Commercialization (OPDC); began at Otsuka in 1988 as a researcher and organic chemist in the CNS group in Japan and contributed to the development of ABILIFY (aripiprazole).
- 1 company
Courtesy Otsuka Pharmaceutical
Current roles
- Otsuka Pharmaceutical Co., Ltd.Executive Vice President, Global Pharmaceutical Strategy (OPDC) · Executive
Appears with
People sharing a company with Nick.
- John Kraus · Otsuka Pharmaceutical Co., Ltd.
- Makoto Inoue · Otsuka Pharmaceutical Co., Ltd.
- Tarek Rabah · Otsuka Pharmaceutical Co., Ltd.
- Tatsuo Higuchi · Otsuka Pharmaceutical Co., Ltd.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.